Molly Henderson
Director Financiero/CFO en PHATHOM PHARMACEUTICALS, INC. .
Fortuna: 884 283 $ al 30/04/2024
Cargos activos de Molly Henderson
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PHATHOM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 05/04/2022 | - |
Director Financiero/CFO | 05/04/2022 | - |
Historial de carrera de Molly Henderson
Antiguos cargos conocidos de Molly Henderson.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CALLIDITAS THERAPEUTICS AB | Director/Miembro de la Junta | 25/06/2020 | 30/05/2023 |
Independent Dir/Board Member | - | 30/05/2023 | |
UROGEN PHARMA LTD. | Comptroller/Controller/Auditor | 01/10/2020 | 25/03/2022 |
Director Financiero/CFO | 01/10/2020 | 25/03/2022 | |
AYALA PHARMACEUTICALS, INC. | Director Financiero/CFO | 06/06/2018 | 25/09/2020 |
IOVANCE BIOTHERAPEUTICS, INC. | Director Financiero/CFO | 08/06/2015 | 01/08/2016 |
Contacto de Relaciones con Inversores | 08/06/2015 | 01/08/2016 | |
VIRTUALSCOPICS INC | Director Financiero/CFO | 01/05/2003 | 31/08/2013 |
Secretario Corporativo | 02/11/2009 | 31/08/2013 | |
ULTRALIFE CORPORATION | Comptroller/Controller/Auditor | 01/08/2000 | 01/08/2002 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | - | - |
Formación de Molly Henderson.
State University of New York at Buffalo | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
Suecia | 2 |
Operativa
Director of Finance/CFO | 5 |
Comptroller/Controller/Auditor | 4 |
Corporate Secretary | 1 |
Sectorial
Health Technology | 6 |
Commercial Services | 3 |
Producer Manufacturing | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 5 |
---|---|
ULTRALIFE CORPORATION | Producer Manufacturing |
IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
CALLIDITAS THERAPEUTICS AB | Health Technology |
UROGEN PHARMA LTD. | Health Technology |
PHATHOM PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
VirtualScopics, Inc.
VirtualScopics, Inc. Miscellaneous Commercial ServicesCommercial Services VirtualScopics, Inc. provides quantitative imaging solutions currently serving the pharmaceutical, biotechnology and medical device industries. It provides image analysis software tools and applications which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. The company's therapeutic area expertise includes oncology, rheumatoid arthritis, osteoarthritis, neurology, cardiovascular, muscle and fat measurements and COPD studies utilizing MRI, PET, CT, Ultrasound and X-Ray imaging modalities. VirtualScopics was founded by Saara Totterman, Kevin J. Parker, Jose Tamez-Pena and Edward Ashton in July 2000 and is headquartered in Rochester, NY. | Commercial Services |
Advaxis, Inc.
Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Molly Henderson
- Experiencia